Vimarsana
Biggest News Aggregation in the World

Page 17 - Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sclerosis Today - Breaking & Trending Today

Companies pan for marketing gold in vaccines - Vimarsana News

Companies pan for marketing gold in vaccines

Companies pan for marketing gold in vaccines For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19 vaccination. "They mentioned it like it was an amenity, like 'We have a swimming pool and a vaccination program,'" said Crow, a librarian in southern Maryland. "It was definitely appealing to me." Vaccines, she felt, would help ease her concerns about whether a congregate living situat...

Simulating an overactive autoimmune response leads to changes in the brain region - Vimarsana News

Simulating an overactive autoimmune response leads to changes in the brain region

Researchers at the University of Tsukuba in Japan show that simulating an overactive autoimmune response in mice leads to changes in the hippocampal region of the brain.

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis - Vimarsana News

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis In the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients with coexisting medical conditions have been noted to be at a higher risk of progressive and severe disease. Patients with multiple sclerosis (MS), who are often on immunosuppressive therapy, may be among these high-risk groups. A new study, released on the medRxiv* preprint server, examines the associations between immunosuppressive disease-modifying ther...

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue - Vimarsana News

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS). John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, "A Biomarker for Cognitive Fatigue in MS using Functional Imaging". The study team includes Glenn Wylie, DPhil, director of the Rocc...

Study shows how genetic mutations lead to kidney cysts in tuberous sclerosis complex - Vimarsana News

Study shows how genetic mutations lead to kidney cysts in tuberous sclerosis complex

Study shows how genetic mutations lead to kidney cysts in tuberous sclerosis complex Tuberous sclerosis complex (TSC) afflicts as many as two million people around the world, affecting multiple organs, including lungs, brain, skin, and kidneys. In about 80 percent of cases, it causes cysts and benign tumors to form in the kidney, eventually resulting in kidney failure. It's known that the disease is triggered by genetic mutations, but how these mutations lead to the formation of kidney cysts has been poorly understood - until now. Nephrologist Manoocher Soleimani, MD, a professor in The Unive...